Literature DB >> 19036457

Dendritic cells--at the front-line of pathogen attack.

Kenneth C McCullough1, Nicolas Ruggli, Artur Summerfield.   

Abstract

Efficient immune defence function is dependent on the role played by dendritic cells (DCs), particularly the interaction between conventional DC (cDC) and plasmacytoid DC (pDC), together with other monocytic cells. This functionality of immune defences is open to manipulation by viral pathogens infecting DC, a situation further complicated by the diversity of mechanisms employed by different viruses and the subset of DC involved. The present review uses two virus examples--classical swine fever virus (CSFV) and porcine circovirus type 2 (PCV2)--to demonstrate the complexity of this host-pathogen scenario. CSFV is a monocytotropic RNA virus infecting and replicating in both cDC and pDC. This virus employs its non-structural Npro protein for antagonizing the Type I interferon (IFN) induction pathway. The Npro protein promotes proteasomal degradation of interferon regulatory factor (IRF)3, particularly notable in cDC. In contrast, CSFV infection induces IFNalpha production by pDC, probably due to a lack of interference by the Npro protein with the IRF7 more prominent in pDC. Such ability of the virus to inhibit cDC while augmenting IFNalpha production by pDC might lead to an exaggerated pDC response, relating to the immunopathological characteristics of the disease. PCV2 is an ssDNA containing virus, which in contrast to CSFV is inefficient in its capacity to replicate in DC. Recent evidence suggests that virus replication occurs in endothelial cells, with the DC being more involved through their particularly elevated endocytosis of the virus. PCV2 can accumulate to high levels both in vitro and in vivo, a phenomenon dependent on the virus capsid protein, inferring that the viral capsid or genome impedes DC endocytic degradation of the virus. Nevertheless, the presence of PCV2 in cDC does not interfere with processing of other antigens. The immunoregulatory characteristics of PCV2 are manifest as impairment of "danger" recognition by cells of the innate defences. This varies dependent on the "danger" signal and the cells responding, especially when one compares cDC and pDC. Overall, the PCV2-induced immunomodulation contrasts with that of CSFV in being a property dependent on the viral genome, particularly the dsDNA replicative form, and with immunoregulatory capacity for both cDC and pDC. Moreover, PCV2 compromises immune defence development against other pathogens rather than itself. In conclusion, the DC family represents a critical immune defence element open to modulation by virus infection, with serious consequences for host resistance to disease. The characteristics of the immune modulation depend on the virus and the DC subsets involved. Overall, the roles played by the pDC can be decisive in shaping the outcome of the infection and the characteristics of the virus-induced immunocompromisation.

Entities:  

Mesh:

Year:  2008        PMID: 19036457     DOI: 10.1016/j.vetimm.2008.10.290

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  14 in total

1.  Contribution of a TANK-binding kinase 1-interferon (IFN) regulatory factor 7 pathway to IFN-γ-induced gene expression.

Authors:  Matthias Farlik; Birgit Rapp; Isabelle Marie; David E Levy; Amanda M Jamieson; Thomas Decker
Journal:  Mol Cell Biol       Date:  2012-01-17       Impact factor: 4.272

2.  Early secreted antigenic target of 6-kDa protein of Mycobacterium tuberculosis primes dendritic cells to stimulate Th17 and inhibit Th1 immune responses.

Authors:  Xisheng Wang; Peter F Barnes; Fangfang Huang; Ivana B Alvarez; Pierre F Neuenschwander; David R Sherman; Buka Samten
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

3.  Co-expression of host and viral microRNAs in porcine dendritic cells infected by the pseudorabies virus.

Authors:  Anna Anselmo; Laurence Flori; Florence Jaffrezic; Teresa Rutigliano; Maria Cecere; Naima Cortes-Perez; François Lefèvre; Claire Rogel-Gaillard; Elisabetta Giuffra
Journal:  PLoS One       Date:  2011-03-08       Impact factor: 3.240

4.  Characterization of porcine dendritic cell response to Streptococcus suis.

Authors:  Marie-Pier Lecours; Mariela Segura; Claude Lachance; Tufaria Mussa; Charles Surprenant; Maria Montoya; Marcelo Gottschalk
Journal:  Vet Res       Date:  2011-06-02       Impact factor: 3.683

Review 5.  Porcine Dendritic Cells and Viruses: An Update.

Authors:  Giulia Franzoni; Simon P Graham; Silvia Dei Giudici; Annalisa Oggiano
Journal:  Viruses       Date:  2019-05-16       Impact factor: 5.048

6.  Vector uncoating limits adeno-associated viral vector-mediated transduction of human dendritic cells and vector immunogenicity.

Authors:  Axel Rossi; Léa Dupaty; Ludovic Aillot; Liang Zhang; Célia Gallien; Michael Hallek; Margarete Odenthal; Sahil Adriouch; Anna Salvetti; Hildegard Büning
Journal:  Sci Rep       Date:  2019-03-06       Impact factor: 4.379

7.  Monocyte-Derived Dendritic Cells as Model to Evaluate Species Tropism of Mosquito-Borne Flaviviruses.

Authors:  Obdulio García-Nicolás; Marta Lewandowska; Meret E Ricklin; Artur Summerfield
Journal:  Front Cell Infect Microbiol       Date:  2019-01-28       Impact factor: 5.293

8.  Antihelminthic niclosamide modulates dendritic cells activation and function.

Authors:  Chieh-Shan Wu; Yi-Rong Li; Jeremy J W Chen; Ying-Che Chen; Chiang-Liang Chu; I-Hong Pan; Yu-Shan Wu; Chi-Chen Lin
Journal:  Cell Immunol       Date:  2013-12-28       Impact factor: 4.868

9.  Acute induction of cell death-related IFN stimulated genes (ISG) differentiates highly from moderately virulent CSFV strains.

Authors:  Patricia Renson; Yannick Blanchard; Mireille Le Dimna; Hélène Felix; Roland Cariolet; André Jestin; Marie-Frédérique Le Potier
Journal:  Vet Res       Date:  2009-10-01       Impact factor: 3.683

Review 10.  Peptide-Based Vaccines: Foot-and-Mouth Disease Virus, a Paradigm in Animal Health.

Authors:  Mar Forner; Rodrigo Cañas-Arranz; Sira Defaus; Patricia de León; Miguel Rodríguez-Pulido; Llilianne Ganges; Esther Blanco; Francisco Sobrino; David Andreu
Journal:  Vaccines (Basel)       Date:  2021-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.